A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

NCT06248515 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Thymoma
Thymic Carcinoma

Interventions

DRUG: Sacituzumab govitecan-hziy

Sponsor

Georgetown University

Collaborators

[object Object]